South Africa Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

South Africa Pharmaceuticals and Healthcare Report Q3 2013 Jul 10th 2013, 00:00, by rnrmahesh BMI View: South Africa is the best investment opportunity for multinational drugmakers seeking to enter the African market. The country currently boasts the largest medicines market on the continent by value, with a double-digit increase in expenditure expected in the medium and long terms. However, we caution there are downside risks to our bullish outlook. These stem from increasing government pressure to contain costs in the relatively small private sector (currently a gold mine for drugmakers); and long, inefficient approval times – years in some cases – which will remain the biggest deterrent to investment in the sector. Headline Expenditure … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=106031. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/south-africa-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions